Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(15 sites)
South Korea
Buchen Sejong Hospital, Bucheon-si Seoul National University Bundang Hospital, Bundang Dong-A University Hospital, Busan Keimyung University Dongsan Hospital, Daegu GangNeung Asan Hospital, Gangneung Chonnam National University Hospital, Gwangju Asan Medical Center, Seoul Korea University Anam Hospital, Seoul Samsung Medical Center, Seoul Seoul National University Hospital, Seoul Ajou University Hospital, Suwon St. Vincent's Hospital, Catholic University of Korea, Suwon Eulji University Uijeongbu Hospital, Uijeongbu-si Ulsan University Hospital, Ulsan Pusan National University Yangsan Hospital, Yangsan